193 related articles for article (PubMed ID: 11506304)
1. Heterochronous development of intrahepatic cholangiocellular carcinoma following hepatocellular carcinoma in a hepatitis B virus carrier.
Shiozawa K; Ishii K; Mori T; Takamura N; Ikehara T; Shinohara M; Kawafune T; Sumino Y; Nonaka H
Intern Med; 2001 Jul; 40(7):624-30. PubMed ID: 11506304
[TBL] [Abstract][Full Text] [Related]
2. Combined hepatocellular and cholangiocarcinoma: clinical features and prognostic study in a Thai population.
Chantajitr S; Wilasrusmee C; Lertsitichai P; Phromsopha N
J Hepatobiliary Pancreat Surg; 2006; 13(6):537-42. PubMed ID: 17139428
[TBL] [Abstract][Full Text] [Related]
3. [Synchronous double primary hepatic cancer: hepatocellular carcinoma and intrahepatic cholangiocarcinoma].
Kim JO; Jun DW; Jang K
Korean J Gastroenterol; 2013 Aug; 62(2):135-9. PubMed ID: 24133714
[No Abstract] [Full Text] [Related]
4. Potential diagnostic performance of contrast-enhanced ultrasound and tumor markers in differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and cholangiocarcinoma.
Huang XW; Huang Y; Chen LD; Wang Z; Yang Z; Liu JY; Xie XY; Lu MD; Shen SL; Wang W
J Med Ultrason (2001); 2018 Apr; 45(2):231-241. PubMed ID: 29052791
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic features of patients with intrahepatic cholangiocarcinoma who are seropositive for alpha-fetoprotein-L3 and those with combined hepatocellular and cholangiocarcinoma.
Okuda H; Shiratori K; Yamamoto M; Takasaki K; Nakano M
J Gastroenterol Hepatol; 2006 May; 21(5):869-73. PubMed ID: 16704538
[TBL] [Abstract][Full Text] [Related]
6. Combined hepatocellular and cholangiocellular carcinoma in a non-cirrhotic liver.
Shiraishi M; Takushi Y; Simoji H; Oshiro T; Shinzato S; Tanigawa N; Kusano T; Muto Y
J Gastroenterol; 1998 Aug; 33(4):593-6. PubMed ID: 9719250
[TBL] [Abstract][Full Text] [Related]
7. Intrahepatic cholangiocarcinoma detected by elevated levels of alpha-fetoprotein-L3 after hepatectomy for hepatocellular carcinoma in a patient with Budd-Chiari syndrome.
Yamamoto M; Otsubo T; Ariizumi S; Nakano M; Takasaki K
Int Surg; 2005; 90(2):81-4. PubMed ID: 16119710
[TBL] [Abstract][Full Text] [Related]
8. Surgically treated cases of mixed hepatocellular carcinoma and cholangiocarcinoma.
Uenishi T; Hirohashi K; Shuto T; Tsukamoto T; Yamamoto T; Kubo S; Tanaka H; Kinoshita H
Hepatogastroenterology; 2002; 49(46):1083-6. PubMed ID: 12143207
[TBL] [Abstract][Full Text] [Related]
9. Intrahepatic cholangiocarcinoma diagnosed preoperatively as hepatocellular carcinoma.
Yamamoto M; Ariizumi S; Otsubo T; Katsuragawa H; Katagiri S; Nakano M; Takasaki K
J Surg Oncol; 2004 Aug; 87(2):80-3; discussion 83-4. PubMed ID: 15282700
[TBL] [Abstract][Full Text] [Related]
10. Synchronous double primary hepatocellular carcinoma and intrahepatic cholangiocarcinoma: A case report and review of the literature.
Qu MM; Zhu YH; Li YX; Li ZF; Li JK; Xu YS; Shrestha M; Lei JQ
Medicine (Baltimore); 2021 Nov; 100(46):e27349. PubMed ID: 34797273
[TBL] [Abstract][Full Text] [Related]
11. Surgery for mixed hepatocellular and cholangiocellular carcinoma.
Uenishi T; Hirohashi K; Shuto T; Yamamoto T; Kubo S; Tanaka H; Ikebe T; Kinoshita H
Hepatogastroenterology; 2000; 47(33):832-4. PubMed ID: 10919041
[TBL] [Abstract][Full Text] [Related]
12. HBV-associated intrahepatic cholangiocarcinoma with high serum alpha-fetoprotein: a case report with review of literature.
Wang C; Jing H; Sha D; Wang W; Chen J; Cui Y; Han J
BMC Infect Dis; 2016 Jun; 16():295. PubMed ID: 27301956
[TBL] [Abstract][Full Text] [Related]
13. [A comparative study of intrahepatic cholangiocarcinoma and hepatocellular carcinoma with reference to clinical features and prognosis].
Hu JY; Zhou HB; Liu WD; Zhang J; Hu HP; Liu J
Zhonghua Gan Zang Bing Za Zhi; 2019 Jul; 27(7):511-515. PubMed ID: 31357776
[No Abstract] [Full Text] [Related]
14. Nomogram based on inflammatory indices for differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma.
Chen L; Zeng F; Yao L; Fang T; Liao M; Long J; Xiao L; Deng G
Cancer Med; 2020 Feb; 9(4):1451-1461. PubMed ID: 31903730
[TBL] [Abstract][Full Text] [Related]
15. Contrast-enhanced ultrasound in association with serum biomarkers for differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Yang J; Zhang YH; Li JW; Shi YY; Huang JY; Luo Y; Liu JB; Lu Q
World J Gastroenterol; 2020 Dec; 26(46):7325-7337. PubMed ID: 33362387
[TBL] [Abstract][Full Text] [Related]
16. Intrahepatic cholangiocarcinoma with increased serum CYFRA 21-1 level.
Kashihara T; Ohki A; Kobayashi T; Sato T; Nishizawa H; Ogawa K; Tako H; Kawakami F; Tsuji M; Tamaoka K
J Gastroenterol; 1998 Jun; 33(3):447-53. PubMed ID: 9658330
[TBL] [Abstract][Full Text] [Related]
17. A resected case of a small hepatocellular carcinoma developing within the bile duct.
Yasui O; Sato T; Andoh H; Kurokawa T; Watanabe D; Sageshima M; Nanjo H
J Hepatobiliary Pancreat Surg; 2004; 11(3):193-6. PubMed ID: 15235893
[TBL] [Abstract][Full Text] [Related]
18. A case of metachronous cholangiocellular and hepatocellular carcinoma with good prognosis.
Kosone T; Takagi H; Hamada T; Kakizaki S; Takehara K; Ohwada S; Mori M
Hepatogastroenterology; 2005; 52(64):1228-32. PubMed ID: 16001668
[TBL] [Abstract][Full Text] [Related]
19. Combined hepatocellular and cholangiocellular carcinoma.
Murakami T; Kim T; Tomoda K; Narumi Y; Sakon M; Wakasa K; Nakamura H
Radiat Med; 1997; 15(4):243-6. PubMed ID: 9311042
[TBL] [Abstract][Full Text] [Related]
20. Combined hepatocellular carcinoma and cholangiocarcinoma (biphenotypic) tumors: clinical characteristics, imaging features of contrast-enhanced ultrasound and computed tomography.
Li R; Yang D; Tang CL; Cai P; Ma KS; Ding SY; Zhang XH; Guo DY; Yan XC
BMC Cancer; 2016 Feb; 16():158. PubMed ID: 26917546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]